Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Abstract: A serving apparatus including a main housing, a main receptacle, a checkout port, a display region including a display device, an RFID first detector including a first antenna, an RFID second detector including a second antenna, a data storage device, and a processor is disclosed. The RFID first detector is configured to detect and collect RFID signals coming in from the receptacle and to register a detected article as a checked-in article. The RFID second detector is RF isolated from the RFID first detector and configured to check out a checked-in article. The processor is configured to classify a checked-in article as a floating article if the checked-in article is not detected by the RFID first detector or the RFID second detector for a time exceeding a threshold time.

Abstract: A presentation apparatus comprising a main receptacle, an article detection device, a processing device and a local data storage; wherein the main receptacle is to hold articles for presentation and to permit removal of articles for viewing, and wherein the processing device is to execute instructions to obtain article specific information of an article from an external data source upon receipt of article identification data of the article from the article detection device, to store said article specific information in said local data storage, and to utilize said article specific information to generate and display presentation information of the article, the presentation information including the article specific information in combination with time-variant information which is non-specific to the article.

Abstract: An apparatus comprising a main receptacle, a first detector, a second detector and a processor; wherein said main receptacle is to hold articles for customer selection, said first detector is to detect presence of an article on said main receptacle, said second detector is to detect an article after said article has been removed from said main receptacle; and wherein the processor is to collect identification information of an article upon introduction of said article into the main receptacle during a serving session and to register introduction of said article, and wherein the processor is to check out or de-register said article from said serving session upon detection of presence of said article at said second detector.

Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Abstract: Purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences are provided.

Abstract: An acupuncture device can include a frame, an enclosure disposed on the frame to protect the frame, multiple stimulators mounted on the frame. The stimulators can be electrically coupled with a controller that transmits electric pulses to the stimulators for electro-acupuncture purpose. The size of the frame is adjustable to fit different body sizes of the users. The stimulators can be carried by the adjustment of the frame. The acupuncture device can also include one or more position references and the stimulators are positioned at relative distances from the position references. When the size of the frame is adjusted, the stimulators are carried by the frame to new positions that are at relative distances from the position references in proportionality with the extent of adjustment of the frame. Hence, the relative distance between a stimulator and a position reference in light of the size of the frame is maintained.

Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Abstract: An acupuncture device can include a frame, an enclosure disposed on the frame to protect the frame, multiple stimulators mounted on the frame. The stimulators can be electrically coupled with a controller that transmits electric pulses to the stimulators for electro-acupuncture purpose. The size of the frame is adjustable to fit different body sizes of the users. The stimulators can be carried by the adjustment of the frame. The acupuncture device can also include one or more position references and the stimulators are positioned at relative distances from the position references. When the size of the frame is adjusted, the stimulators are carried by the frame to new positions that are at relative distances from the position references in proportionality with the extent of adjustment of the frame. Hence, the relative distance between a stimulator and a position reference in light of the size of the frame is maintained.

Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Abstract: An acupuncture device can include a frame, an enclosure disposed on the frame to protect the frame, multiple stimulators mounted on the frame. The stimulators can be electrically coupled with a controller that transmits electric pulses to the stimulators for electro-acupuncture purpose. The size of the frame is adjustable to fit different body sizes of the users. The stimulators can be carried by the adjustment of the frame. The acupuncture device can also include one or more position references and the stimulators are positioned at relative distances from the position references. When the size of the frame is adjusted, the stimulators are carried by the frame to new positions that are at relative distances from the position references in proportionality with the extent of adjustment of the frame. Hence, the relative distance between a stimulator and a position reference in light of the size of the frame is maintained.

Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.

Abstract: The present invention relates to the use of binding equivalents of monoclonal antibody 31.1, including chimerized and/or humanized versions thereof, antibody fragments as well as competitively binding and co-specific antibodies and antibody fragments, in the treatment of pancreatic cancer.

Abstract: An apparatus comprising a main receptacle, a first detector, a second detector and a processor; wherein said main receptacle is to hold articles for customer selection, said first detector is to detect presence of an article on said main receptacle, said second detector is to detect an article after said article has been removed from said main receptacle; and wherein the processor is to collect identification information of an article upon introduction of said article into the main receptacle during a serving session and to register introduction of said article, and wherein the processor is to check out or de-register said article from said serving session upon detection of presence of said article at said second detector.

Abstract: A presentation apparatus comprising a main receptacle, an article detection device, a processing device and a local data storage; wherein the main receptacle is to hold articles for presentation and to permit removal of articles for viewing, and wherein the processing device is to execute instructions to obtain article specific information of an article from an external data source upon receipt of article identification data of the article from the article detection device, to store said article specific information in said local data storage, and to utilize said article specific information to generate and display presentation information of the article, the presentation information including the article specific information in combination with time-variant information which is non-specific to the article.

Abstract: A serving apparatus comprising a main receptacle for holding articles for customer selection, a first detector to detect product identification information associated with an article when said article is first introduced into said main receptacle during a serving session, a data storage device and a processor; wherein the processor is to collect and store said product identification information for use at end of said serving session.

Abstract: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.